The JAK2 Gene V617F Quantitative Test is a specialized diagnostic procedure designed to detect the presence of the V617F mutation in the Janus kinase 2 (JAK2) gene. This mutation is commonly associated with a group of blood cancers known as myeloproliferative neoplasms (MPNs), including polycythemia vera, essential thrombocythemia, and primary myelofibrosis. The test plays a crucial role in the diagnosis and management of these conditions, helping to guide treatment decisions and monitor disease progression.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves a blood sample from the patient. Utilizing advanced molecular techniques, the laboratory professionals accurately quantify the presence of the JAK2 V617F mutation, providing valuable insights into the patient's condition. The cost of the test is 1200 AED, reflecting the specialized nature of the analysis and the expertise required to interpret the results.
Choosing DNA Labs UAE for the JAK2 Gene V617F Quantitative Test ensures patients receive high-quality diagnostic services, benefiting from the lab's commitment to accuracy, confidentiality, and support throughout the testing process.
The "Large Biopsy 3 Test" is a specialized diagnostic procedure offered at DNA Labs UAE, designed to analyze a substantial sample of tissue from the body to detect the presence of diseases, including various types of cancers. This comprehensive test is crucial for patients undergoing diagnosis for suspicious growths or abnormalities identified in earlier screenings. By examining a large biopsy, pathologists can provide a more accurate diagnosis, assess the stage of a disease, and recommend an appropriate treatment plan.
Performed in the state-of-the-art facilities of DNA Labs UAE, this test employs advanced molecular and histopathological techniques to analyze the biopsy sample. The process involves careful preparation of the tissue, followed by detailed microscopic examination and possibly molecular testing to identify specific genetic markers or abnormalities. This thorough approach ensures high diagnostic accuracy and is pivotal in personalized medicine, allowing for treatments tailored to the genetic makeup of a patient's condition.
The cost of the "Large Biopsy 3 Test" at DNA Labs UAE is set at 1200 AED. While the price may seem significant, the value of obtaining a precise diagnosis cannot be overstated, as it directly influences the effectiveness of subsequent medical interventions. Patients choosing DNA Labs UAE for this test can expect not only reliable results but also a supportive and confidential service throughout their diagnostic journey.
The Methylenetetrahydrofolate Reductase (MTHFR) - 2 Variants C677T A1298C Test is a specialized genetic examination offered by DNA Labs UAE, designed to identify mutations in the MTHFR gene. Specifically, this test focuses on two common variants, C677T and A1298C, which have been associated with a range of health issues, including increased risk of cardiovascular diseases, stroke, and certain types of thrombophilia. The MTHFR enzyme plays a crucial role in processing amino acids, the building blocks of proteins, and is vital for a process known as methylation. Alterations in this enzyme's function due to genetic mutations can lead to elevated levels of homocysteine in the blood, a risk factor for various health conditions.
DNA Labs UAE offers this test at a cost of 1200 AED. The process involves a simple blood sample from which DNA is extracted and analyzed for the presence of the C677T and A1298C mutations. This test is essential for individuals with a family history of related health issues or those experiencing symptoms that could be linked to MTHFR mutations. Understanding one's genetic makeup in relation to the MTHFR gene can help in making informed decisions regarding lifestyle, dietary adjustments, and medical interventions to mitigate potential health risks.
The NPM1 Mutation Analysis Exon 12 Insertion Test is a specialized diagnostic procedure aimed at detecting mutations within exon 12 of the Nucleophosmin 1 (NPM1) gene. These mutations are significant because they are frequently observed in patients with acute myeloid leukemia (AML), a type of cancer that affects the blood and bone marrow. Identifying the presence of NPM1 mutations is crucial for the prognosis, treatment planning, and monitoring of AML patients, as these mutations are associated with distinct clinical outcomes and may influence the response to certain therapies.
Performed at DNA Labs UAE, a leading laboratory renowned for its advanced genetic testing capabilities, this test involves analyzing the patient's DNA to search for the specific insertion mutations within exon 12 of the NPM1 gene. The procedure is conducted under strict quality controls to ensure accuracy and reliability of the results.
The cost of the NPM1 Mutation Analysis Exon 12 Insertion Test at DNA Labs UAE is set at 1200 AED. This price reflects the intricate nature of the testing process and the valuable insights it provides to healthcare providers, helping them to tailor treatment strategies that are more effective for patients with AML. By offering this test, DNA Labs UAE contributes to the personalized approach in cancer treatment, enabling better patient care and outcomes.
The QF PCR Panel 131821XY Test is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to provide detailed genetic information. This test utilizes the Quantitative Fluorescent Polymerase Chain Reaction (QF-PCR) technique, which is a highly sensitive method for analyzing specific sequences of DNA. The primary application of this test is in the field of genetic diagnostics, where it can be used to detect chromosomal abnormalities, genetic mutations, or for gender determination purposes.
With a cost of 1200 AED, the QF PCR Panel 131821XY Test is positioned as a valuable option for individuals seeking in-depth genetic analysis. The test is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high-quality standards and reliable results. This test is particularly useful for expecting parents who wish to know more about their unborn child's health and genetic predispositions or for individuals who need detailed genetic information for medical reasons.
DNA Labs UAE is known for its expertise in genetic testing and diagnostics, providing a wide range of services that cater to various health and personal information needs. The QF PCR Panel 131821XY Test stands out as a precise and efficient tool for those looking to gain a deeper understanding of genetic information, backed by the reliability and professionalism of DNA Labs UAE.
The RUNX1-RUNX1T1 AML1-ETO t(8;21) Quantitative Test is a specialized diagnostic assay designed to detect the presence of the RUNX1-RUNX1T1 fusion gene, which results from the translocation between chromosomes 8 and 21, specifically t(8;21)(q22;q22). This genetic abnormality is a hallmark of certain types of acute myeloid leukemia (AML), particularly those classified as M2 under the French-American-British (FAB) classification system. The presence of this fusion gene is associated with a distinct clinical course and has implications for treatment strategies and prognosis.
The test utilizes advanced molecular techniques to quantitatively measure the levels of the RUNX1-RUNX1T1 transcript in the patient's blood or bone marrow samples. This allows for not only the diagnosis of AML with the t(8;21) translocation but also the monitoring of disease progression and response to therapy, making it an invaluable tool in the management of patients with this subtype of leukemia.
Performed at DNA Labs UAE, the RUNX1-RUNX1T1 AML1-ETO t(8;21) Quantitative Test is priced at 1200 AED. DNA Labs UAE is equipped with state-of-the-art facilities and staffed by highly skilled professionals, ensuring accurate and reliable test results. This test represents a critical step in the personalized care of patients with AML, guiding therapeutic decisions and contributing to improved outcomes.
Sickle Cell Mutation Screening Prenatal Test is a crucial examination offered by DNA Labs UAE, designed to detect the presence of sickle cell mutations in unborn babies. This test, priced at 1200 AED, involves analyzing the fetal DNA for specific genetic markers associated with Sickle Cell Anemia (SCA), a severe hereditary blood disorder. SCA affects the shape and functionality of red blood cells, leading to various health complications. Early detection through prenatal screening enables parents and healthcare providers to prepare and implement appropriate management strategies for affected children. Conducted in a state-of-the-art laboratory setting, this test represents a proactive approach to managing genetic health risks and ensuring the well-being of future generations.
The TELAML1 Quantitative Test is a specialized diagnostic procedure designed to detect and measure the presence of the TEL-AML1 fusion gene, which is often associated with certain types of leukemia, particularly Acute Lymphoblastic Leukemia (ALL). This genetic abnormality results from the translocation between chromosomes 12 and 21, and its identification is crucial for the accurate diagnosis, prognosis, and treatment planning for patients affected by this condition.
Performed at DNA Labs UAE, a leading facility in genetic testing, the TELAML1 Quantitative Test employs advanced molecular techniques to ensure precise and reliable results. The test is particularly valuable for monitoring disease progression or response to therapy in patients diagnosed with leukemia.
The cost of the TELAML1 Quantitative Test at DNA Labs UAE is 1200 AED. This investment is essential for those needing detailed genetic insights into their leukemia diagnosis, allowing for tailored treatment approaches and better management of the disease.
The Thiopurine Methyltransferase (TPMT) *2, *3A, *3B, *3C Genotyping Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to analyze specific genetic variants of the TPMT enzyme. These variants, known as *2, *3A, *3B, and *3C, significantly influence the body's ability to metabolize thiopurine drugs, which are commonly prescribed for conditions such as leukemia, autoimmune diseases, and inflammatory bowel disease.
The TPMT enzyme plays a crucial role in determining the optimal dosage of thiopurine medications for individual patients. Variations in the TPMT gene can lead to differences in enzyme activity, affecting drug efficacy and the risk of adverse reactions. Individuals with reduced or absent TPMT activity are at a higher risk of experiencing toxic side effects when taking standard doses of thiopurine drugs.
The genotyping test offered by DNA Labs UAE provides a precise and reliable method for detecting the presence of these critical TPMT variants. By identifying patients' TPMT genotype, healthcare providers can tailor thiopurine drug dosages to optimize therapeutic outcomes and minimize the risk of toxicity. This personalized approach to medication management enhances patient safety and treatment effectiveness.
The cost of the TPMT *2, *3A, *3B, *3C Genotyping Test at DNA Labs UAE is 1200 AED. This investment in precision medicine enables patients and their healthcare teams to make informed decisions regarding thiopurine therapy, ultimately leading to better health outcomes and improved quality of life for those affected by conditions requiring thiopurine treatment.
The TORCH Panel Real-Time PCR Test is a highly sensitive and specific diagnostic tool used to detect infections that could potentially harm an unborn baby or a newborn. This panel screens for a group of infections known as TORCH - Toxoplasmosis, Other agents (such as Syphilis, Varicella-Zoster Virus, and Parvovirus B19), Rubella, Cytomegalovirus (CMV), and Herpes Simplex Virus (HSV). These infections can lead to severe fetal anomalies or birth defects if transmitted from mother to child during pregnancy.
Performed at DNA Labs UAE, the TORCH Panel Real-Time PCR Test employs polymerase chain reaction (PCR) technology to amplify and detect the DNA or RNA of the pathogens causing these infections. This makes the test highly accurate in identifying active infections, allowing for timely intervention and management to safeguard maternal and fetal health.
The cost of the TORCH Panel Real-Time PCR Test at DNA Labs UAE is 1200 AED. Considering the critical information it provides, the test represents a valuable investment in prenatal care, helping to ensure the health and well-being of both mother and child.
